🎉 M&A multiples are live!
Check it out!

CollPlant Valuation Multiples

Discover revenue and EBITDA valuation multiples for CollPlant and other public comps.

See CollPlant Valuation Multiples

CollPlant Overview

About CollPlant

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.


Founded

1981

HQ

United States of America
Employees

75

Website

collplant.com

Financials

LTM Revenue $1.7M

LTM EBITDA n/a

EV

$29.8M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

CollPlant Financials

CollPlant has a last 12-month revenue of $1.7M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, CollPlant achieved revenue of $11.0M and an EBITDA of -$6.4M.

CollPlant expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See CollPlant valuation multiples based on analyst estimates

CollPlant P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $0.3M $11.0M $0.5M $1.7M XXX
Gross Profit $13.6M -$0.1M $9.0M XXX XXX
Gross Margin 4561% -1% 1988% XXX XXX
EBITDA -$16.0M -$6.4M n/a n/a XXX
EBITDA Margin -5358% -58% NaN% 0% XXX
Net Profit $0.2M -$16.9M -$7.0M XXX XXX
Net Margin 79% -154% -1556% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

CollPlant Stock Performance

As of February 10, 2025, CollPlant's stock price is $4.

CollPlant has current market cap of $41.9M, and EV of $29.8M.

See CollPlant trading valuation data

CollPlant Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$29.8M $41.9M XXX XXX XXX XXX $-0.98

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

CollPlant Valuation Multiples

As of February 10, 2025, CollPlant has market cap of $41.9M and EV of $29.8M.

CollPlant's trades at 17.6x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate CollPlant's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for CollPlant and 10K+ public comps

CollPlant Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $29.8M XXX XXX XXX
EV/Revenue 66.1x XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E -2.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get CollPlant Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

CollPlant Valuation Multiples

CollPlant's NTM/LTM revenue growth is 624%

CollPlant's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, CollPlant's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate CollPlant's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for CollPlant and other 10K+ public comps

CollPlant Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -96% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth n/a XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 96% XXX XXX XXX XXX
Opex to Revenue 150% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

CollPlant Public Comps

See valuation multiples for CollPlant public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Lineage Cell Therapeutics XXX XXX XXX XXX XXX XXX
Arovella Therapeutics XXX XXX XXX XXX XXX XXX
Aroa Biosurgery XXX XXX XXX XXX XXX XXX
Cynata Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

CollPlant M&A and Investment Activity

CollPlant acquired  XXX companies to date.

Last acquisition by CollPlant was  XXXXXXXX, XXXXX XXXXX XXXXXX . CollPlant acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by CollPlant

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About CollPlant

When was CollPlant founded? CollPlant was founded in 1981.
Where is CollPlant headquartered? CollPlant is headquartered in United States of America.
How many employees does CollPlant have? As of today, CollPlant has 75 employees.
Who is the CEO of CollPlant? CollPlant's CEO is Mr. Eran Rotem.
Is CollPlant publicy listed? Yes, CollPlant is a public company listed on NAS.
What is the stock symbol of CollPlant? CollPlant trades under CLGN ticker.
When did CollPlant go public? CollPlant went public in 2021.
Who are competitors of CollPlant? Similar companies to CollPlant include e.g. Lineage Cell Therapeutics, Arovella Therapeutics, Aroa Biosurgery, Cynata Therapeutics.
What is the current market cap of CollPlant? CollPlant's current market cap is $41.9M
What is the current revenue of CollPlant? CollPlant's last 12-month revenue is $1.7M.
What is the current EV/Revenue multiple of CollPlant? Current revenue multiple of CollPlant is 17.6x.
What is the current revenue growth of CollPlant? CollPlant revenue growth between 2023 and 2024 was -96%.
Is CollPlant profitable? Yes, CollPlant is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.